Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price fell 9.8% during trading on Wednesday . The company traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). 41,420 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).
Proteome Sciences Trading Up 40.4 %
The firm has a market capitalization of £14.17 million, a PE ratio of -480.00 and a beta of 0.07. The business’s 50 day simple moving average is GBX 2.97 and its 200 day simple moving average is GBX 3.12.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- How to Calculate Stock Profit
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is a buyback in stocks? A comprehensive guide for investors
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Invest in Blue Chip Stocks
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
